1426 related articles for article (PubMed ID: 32428551)
21. Reply to a Letter to the Editor: can we really consider tumor size and surgical extent as predictive factors for recurrence in clinically early-stage papillary thyroid carcinoma patients?
Roh JL; Kim JW
Am J Surg; 2016 Nov; 212(5):1031-1032. PubMed ID: 27523924
[No Abstract] [Full Text] [Related]
22. Reply to C. Bal et al.
Xing M
J Clin Oncol; 2015 Aug; 33(22):2483-4. PubMed ID: 26124484
[No Abstract] [Full Text] [Related]
23. Letter to the Editor regarding, "Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis".
Yu ST; Xiao ZZ
Oral Oncol; 2019 Apr; 91():132-133. PubMed ID: 30773348
[No Abstract] [Full Text] [Related]
24. Reply to C. Bal et al and M. Xing.
Yarchoan M; LiVolsi VA; Brose MS
J Clin Oncol; 2015 Aug; 33(22):2483. PubMed ID: 26124481
[No Abstract] [Full Text] [Related]
25. [Clinicopathologic and molecular features of cribriform morular variant of papillary thyroid carcinoma].
Cui XJ; Zhao HO; Su P; Chen J; Zhang RY; Pan Y; Ouyang XM; Liu J; Zhang JQ; Yang Y; Yang R; Ding L; Liu ZY
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):354-359. PubMed ID: 29783802
[No Abstract] [Full Text] [Related]
26. Variants in microRNA genes in familial papillary thyroid carcinoma.
Tomsic J; Fultz R; Liyanarachchi S; Genutis LK; Wang Y; Li W; Volinia S; Jazdzewski K; He H; Wakely PE; Senter L; de la Chapelle A
Oncotarget; 2017 Jan; 8(4):6475-6482. PubMed ID: 28031538
[TBL] [Abstract][Full Text] [Related]
27. [DICER1 mutated, solid/trabecular thyroid papillary carcinoma in an 11-year-old child].
Ravella L; Lopez J; Descotes F; Lifante JC; David C; Decaussin-Petrucci M
Ann Pathol; 2018 Oct; 38(5):316-320. PubMed ID: 29884466
[TBL] [Abstract][Full Text] [Related]
28. Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls.
Kern B; Coppin L; Romanet P; Crépin M; Szuster I; Renaud F; Leteurtre E; Frénois F; Wemeau JL; Carnaille B; Cardot-Bauters C; Do Cao C; Pigny P
Eur J Med Genet; 2017 Mar; 60(3):178-184. PubMed ID: 28089742
[TBL] [Abstract][Full Text] [Related]
29. Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation.
Brauckhoff M; Gimm O; Hinze R; Ukkat J; Brauckhoff K; Dralle H
Thyroid; 2002 Jul; 12(7):557-61. PubMed ID: 12193298
[TBL] [Abstract][Full Text] [Related]
30. Authors' reply to the Letter to Editor "Thyroglobulin antibodies may serve as predictive marker for papillary thyroid carcinoma in indeterminate cytology: Acceptable or not?".
Karatzas T; Vasileiadis I
Am J Surg; 2018 Jul; 216(1):178-179. PubMed ID: 28237046
[No Abstract] [Full Text] [Related]
31. Simultaneous medullary and papillary thyroid carcinomas in carriers of the V804M RET germline mutation-a spurious association?
Machens A; Dralle H
Surgery; 2010 Jun; 147(6):895-6; author reply 896-7. PubMed ID: 20494215
[No Abstract] [Full Text] [Related]
32. Inherited Risk Factors for Nonmedullary Thyroid Carcinoma.
Malchoff CD
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4287-e4289. PubMed ID: 33739387
[No Abstract] [Full Text] [Related]
33. Reply to Letter to the Editor regarding anaplastic thyroid carcinoma.
Ryan NA; Lazic D
Head Neck; 2016 Aug; 38(8):1291. PubMed ID: 27198627
[No Abstract] [Full Text] [Related]
34. Novel germline RET mutation segregating with papillary thyroid carcinomas.
Rey JM; Brouillet JP; Fonteneau-Allaire J; Boneu A; Bastié D; Maudelonde T; Pujol P
Genes Chromosomes Cancer; 2001 Dec; 32(4):390-1. PubMed ID: 11746981
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of MEDAG gene expression in papillary thyroid microcarcinoma: associations with histological features, regional lymph node metastasis and prognosis.
Song Y; Fu LJ; Li HT; Qiu XG
Sci Rep; 2019 Apr; 9(1):5800. PubMed ID: 30967566
[TBL] [Abstract][Full Text] [Related]
36. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
[TBL] [Abstract][Full Text] [Related]
37. Cribriform-morular variant of papillary thyroid carcinoma: ultrastructural study and somatic/germline mutation analysis of the APC gene.
Kameyama K; Mukai M; Takami H; Ito K
Ultrastruct Pathol; 2004; 28(2):97-102. PubMed ID: 15205109
[TBL] [Abstract][Full Text] [Related]
38. The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer.
Xing M
Clin Endocrinol (Oxf); 2005 Sep; 63(3):263-6. PubMed ID: 16117812
[TBL] [Abstract][Full Text] [Related]
39. Letter to the Editor: Reply.
Ito Y; Miyauchi A; Hirokawa M
World J Surg; 2017 Oct; 41(10):2645-2646. PubMed ID: 28332059
[No Abstract] [Full Text] [Related]
40. Cribriform-Morular Variant of Papillary Thyroid Carcinoma With Poorly Differentiated Features: A Case Report With Immunohistochemical and Molecular Genetic Analysis.
Corean J; Furtado LV; Kadri S; Segal JP; Emerson LL
Int J Surg Pathol; 2019 May; 27(3):294-304. PubMed ID: 30176755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
